770-20-7

Usage

Uses

Used in Pharmaceutical Industry:
6-Acetamido-2-pyridinol is used as an intermediate in the synthesis of various pharmaceutical products, contributing to the development of new medications and therapies.
Used in Pesticide Production:
As a key component in the production of pesticides, 6-Acetamido-2-pyridinol helps in the development of effective and safe agricultural chemicals to protect crops and enhance food security.
Used in Metal Ion Detection and Analysis:
6-Acetamido-2-pyridinol serves as a chelating agent, playing a crucial role in the detection and analysis of metal ions, which is essential in various scientific and industrial applications.
Used in Neurological Disorder Treatment:
6-Acetamido-2-pyridinol has shown potential for use in the treatment of certain neurological disorders, offering a promising avenue for research and development in the field of neurology.
Used as an Anti-Inflammatory Agent:
6-Acetamido-2-pyridinol has demonstrated anti-inflammatory properties, making it a potential candidate for the development of new anti-inflammatory drugs to treat various inflammatory conditions.
Used for Antioxidant and Antimicrobial Properties:
6-Acetamido-2-pyridinol has been studied for its potential antioxidant and antimicrobial properties, indicating its potential use in the development of new antioxidants and antimicrobial agents to combat oxidative stress and infections, respectively.

Upstream product

• 858840-01-4 2-acetoxy-6-acetylamino-pyridine 
• 5154-00-7 6-amino-pyridin-2-ol 
• 108-24-7 acetic anhydride 
• 5154-00-7 6-aminopyridine-2(1H)-one 
• 75-36-5 acetyl chloride 
• 6994-14-5 2-Acetamino-pyridin-1-oxid 
• 5231-96-9 N-(2-pyridyl)acetamide 
• 504-29-0 2-aminopyridine 
• 64-19-7 acetic acid 
• 141-86-6 2.6-diaminopyridine 

Relevant academic research and scientific papers

Carbazole and Carboline Compounds for Use in the Diagnosis, Treatment, Alleviation or Prevention of Disorders Associated with Amyloid or Amyloid-Like Proteins

The present invention relates to novel compounds that can be employed in the diagnosis, treatment, alleviation or prevention of a group of disorders and abnormalities associated with amyloid proteins and amyloid-like proteins, such as Alzheimer's disease. Precursors for the preparation of the compounds according to the present invention are also provided.

CARBAZOLE AND CARBOLINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH AMYLOID OR AMYOLID-LIKE PROTEINS

The present invention relates to novel compounds that can be employed in the diagnosis, treatment, alleviation or prevention of a group of disorders and abnormalities associated with amyloid proteins and amyloid-like proteins, such as Alzheimer's disease. Precursors for the preparation of the compounds according to the present invention are also provided.

NMR crystallography of 2-acylamino-6-[1H]-pyridones: Solid-state NMR, GIPAW computational, and single crystal X-ray diffraction studies

2-Acylamino-6-[1H]-pyridones [acyl = RCO, where R = methyl (1), ethyl (2), iso-propyl (3), tert-butyl (4), and 1-adamantyl (5)] have been synthesized and characterized by NMR spectroscopy. From three congeners, 2, 3 and 5, also single crystal X-ray structures have been solved. For these derivatives GIPAW calculations acts as a "bridge" between solid-state NMR data and calculated chemical shifts based on X-ray determined geometry. In crystals all three compounds exist as pyridone tautomers possessing similar six-membered ring structure stabilized by intramolecular CO?HN hydrogen bond. Theoretical GIPAW calculated and experimental 13C and 15N CPMAS NMR shifts are in excellent agreement with each other.

Self-assembly of organocatalysts: Fine-tuning organocatalytic reactions

(Chemical Equation Presented) A cat. with two tales: Hydrogen-bonding interactions between achiral pyridinone additives and unselective chiral proline-derived organocatalysts (see picture) result in highly effective catalysts for the Michael addition of n